Cite
HARVARD Citation
Kadouh, N. et al. (2022). Mexiletine: An adjuvant option for refractory pain in patients with sickle cell disease and comorbid autism spectrum disorder. Pediatric blood & cancer. 69 (8), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kadouh, N. et al. (2022). Mexiletine: An adjuvant option for refractory pain in patients with sickle cell disease and comorbid autism spectrum disorder. Pediatric blood & cancer. 69 (8), p. n/a. [Online].